Related Experiment Video
Updated: May 11, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Investigating immune cell infiltration and gene expression features in pterygium pathogenesis
Ji Yang1, Ya-Nan Chen1, Chen-Yan Fang1
1Department of Ophthalmology, The Eye Disease Clinical Medical Research Center of Yunnan Province, Second People's Hospital of Yunnan Province, The Affiliated Hospital of Yunnan University, The Eye Disease Clinical Medical Center of Yunnan Province, Kunming, China.
This study reveals key gene expression changes and immune cell alterations in pterygium (eye growth). Researchers identified FN1 and SPRR1B as potential biomarkers for this condition.
Area of Science:
- Ophthalmology
- Molecular Biology
- Immunology
Background:
- Pterygium is a common eye condition involving conjunctival tissue growth, impacting patient quality of life.
- The molecular drivers and immune microenvironment of pterygium pathogenesis are not fully understood.
Purpose of the Study:
- To investigate gene expression alterations in pterygium tissues post-excision.
- To identify potential diagnostic biomarkers and understand the role of immune cell infiltration in pterygium development.
Main Methods:
- Transcriptomic analysis (RNA sequencing) of clinical pterygium and conjunctival samples.
- Bioinformatics approaches including machine learning (LASSO, SVM-RFE, Random Forest) for biomarker identification.
- Gene Ontology (GO), KEGG, Gene Set Enrichment Analysis (GSEA), and Gene Set Variation Analysis (GSVA) for functional enrichment and immune cell infiltration analysis.
Main Results:
- Identified 52 co-differentially expressed genes (co-DEGs) between datasets, with FN1 and SPRR1B emerging as significant candidate biomarkers.
- Revealed increased Th2 cell infiltration and decreased CD8+ T cell presence in pterygium tissues, indicating immune microenvironment involvement.
- Validated higher expression of FN1 and SPRR1B in pterygium tissues, with potential drug candidates identified.
Conclusions:
- Pterygium pathogenesis involves specific gene expression changes and a distinct immune microenvironment.
- FN1 and SPRR1B show promise as diagnostic biomarkers for pterygium.
- Findings provide a foundation for clinical applications and further research into pterygium treatment.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
09:55Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses
Published on: February 3, 2022